Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Abbott Laboratories Stories

2013-09-30 23:28:04

Reportbuyer.com just published a new market research report: Point of Care Coagulation Testing: World Market 2013-2023 London (PRWEB) September 30, 2013 Report Details In 2011, the global point of care diagnostics market was worth $13.8bn, with high single-digit growth from the year before. Despite being a vast and mature market, there are number of sectors likely to experience fast growth during the next 10 years. Much of this growth is linked to the prevalence of a number of diseases...

2013-09-30 08:26:21

NEW YORK, September 30, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Investors' Reports announced new research reports highlighting Abbott Laboratories (NYSE: ABT), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Pacific Biosciences of California (NASDAQ: PACB), Synageva BioPharma Corp. (NASDAQ: GEVA), and Oncothyreon Inc. (NASDAQ: ONTY). Today's readers may access these reports free of charge - including full...

2013-09-19 23:21:39

Reportbuyer.com just published a new market research report: MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts. London (PRWEB) September 19, 2013 Summary Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease (PAD) in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon...

2013-09-19 08:25:11

NEW YORK, September 19, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Johnson & Johnson (NYSE: JNJ), Zoetis Inc. (NYSE: ZTS), Abbott Laboratories (NYSE: ABT), Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), and Baxter International Inc. (NYSE: BAX). Today's readers may access these reports free of charge - including full price targets, industry...

2013-09-17 23:33:23

As The Wall Street Journal published on August 22, Dr. Reddy's launched a generic version of Depakote ER with a warning for life-threatening adverse reactions. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) September 17, 2013 AttorneyOne.com, a recognized authority on law, updated the website...

2013-09-17 08:31:38

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 17, 2013 /PRNewswire/ -- Today, Investors' Reports announced new research reports highlighting Boston Scientific Corporation (NYSE: BSX), Gilead Sciences Inc. (NASDAQ: GILD), Abbott Laboratories (NYSE: ABT), Actavis Inc. (NYSE: ACT), and Covidien plc (NYSE: COV). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst...

2013-09-16 08:28:57

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 16, 2013 /PRNewswire/ -- Today, Investors' Reports announced new research reports highlighting Amgen, Inc. (NASDAQ: AMGN), Gilead Sciences, Inc. (NASDAQ: GILD), Abbott Laboratories (NYSE: ABT), Biogen Idec Inc. (NASDAQ: BIIB), and UnitedHealth Group Inc. (NYSE: UNH). Today's readers may access these reports free of charge - including full price targets, industry analysis and...

2013-08-19 23:22:58

As Businessweek published on August 16, a new lawsuit alleges that Abbott engaged in racketeering when it led an effort to market Depakote for unapproved uses. In light of this news, AttorneyOne, a recognized authority on law, inform that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) August 19, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently...

2013-08-19 23:21:18

421 Pages Report In Vitro Diagnostic (IVD) Market categories the global market by Product Type (Reagents, Instruments & Data Management Systems), Technique (Clinical Chemistry, Immunoassay, Haematology, Molecular Diagnostics) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology) Systems, End Users & by Geography" (PRWEB) August 19, 2013 The "In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique...

2013-08-08 23:17:45

This report studies the global in vitro diagnostics (IVD) market, with forecast to 2017. The IVD market studied in this report has been segmented on the basis of technology, product type, application, end-user, and geography. (PRWEB) August 08, 2013 The “In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer &...